#nmibc
LightNews LightNews
uroweb.org
Low-grade intermediate-risk NMIBC can be safely followed-up with a cystoscopy at 3 months and, if negative, with 6 monthly cystoscopies for 2 years followed by yearly cystoscopies up to 10 years.

#BladderCancer #NMIBC #EAUguidelines

uroweb.org/guidelines/n...
FOLLOW-UP OF PATIENTS WITH NMIBC - Uroweb
This overview represents the updated European Association of Urology (EAU) Guidelines for Non-muscle-invasive Bladder Cancer (NMIBC)
uroweb.org
May 29, 2024 at 2:15 PM
ssjoshi.bsky.social
Packed house at SUO2024 for NMIBC discussion. Our thought leader @drnarayan.com from @emoryuroonc.bsky.social @winshipatemory.bsky.social
Ongoing challenge: how do we manage high risk NMIBC? Especially those with variants?
@valentinagrajales.bsky.social
December 5, 2024 at 5:41 PM
wandering-gu.bsky.social
Awesome talk by @joshmeeks.bsky.social on trial design in NMIBC. Huge need to get away from single arm trials. #SUO24
December 5, 2024 at 5:47 PM
oncodaily.bsky.social
Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management

oncodaily.com/insight/231338

#NMIBC #Cancer #OncoDaily #Oncology #Health #Medicine
oncodaily.com
January 26, 2025 at 4:03 PM
ddshapiro.bsky.social
Proud of my friend @drnarayan.com giving great talk at #suo on cystectomy for NMIBC
December 5, 2024 at 7:04 PM
oncodaily.bsky.social
What is the best strategy in BCG unresponsive HR NMIBC? - Sabine D. Brookman-May
@brookmans76.bsky.social

oncodaily.com/blog/sabine-...

#Cancer #CancerResearch #BladderCancer #CancerTreatment #Urology #Medicine #Health #Oncology #OncoDaily
Sabine D. Brookman-May: What is the best strategy in BCG unresponsive HR NMIBC? - OncoDaily
Sabine D. Brookman-May: What is the best strategy in BCG unresponsive HR NMIBC? / Ashish M. Kamat, cancer, Carme Mir, OncoDaily, Oncology, Sabine D.
oncodaily.com
March 22, 2025 at 8:06 PM
joho.bsky.social
The FDA is approving expensive cancer drugs without RCTs.
🧵

www.medscape.com/viewarticle/...
FDA Bucks Advisors to Approve Mitomycin for NMIBC
The agency set aside concerns about UroGen’s approval trial to greenlight mitomycin intravesical solution for recurrent non-muscle invasive bladder cancer.
www.medscape.com
June 18, 2025 at 11:25 PM
uroweb.org
Low-grade intermediate-risk NMIBC can be safely followed-up with a cystoscopy at 3 months and, if negative, with 6 monthly cystoscopies for 2 years followed by yearly cystoscopies up to 10 years.

#NMIBC #EAUguidelines

uroweb.org/guidelines/n...
EAU Guidelines on Non-muscle-invasive Bladder Cancer - Uroweb
This overview represents the updated European Association of Urology (EAU) Guidelines for Non-muscle-invasive Bladder Cancer (NMIBC)
uroweb.org
November 26, 2024 at 3:16 PM
uroweb.org
🧾 Cheat Sheet on Follow-up for NMIBC

🔹 Risk-based surveillance
🔹 Lifelong follow-up for high-risk patients
🔹 Role of cytology & markers
🔍 No substitute for cystoscopy

Download Cheat Sheet:
uroweb.org/guidelines/n...

#BladderCancer #NMIBC #EAUguidelines
June 19, 2025 at 8:16 AM
jonrosenberg.bsky.social
They found my email. I don't know a thing about bladder cancer and I don't want to. Don't let them make me be a bladder doctor please
Hi Dr. Rosenberg, I hope all is well. I’m reaching out to you as I currently have a US-based investor client who is researching treatments for bladder cancer. As part of this research, they are trying to connect with doctors who are treating patients with NMIBC (Non-Muscle Invasive Bladder Cancer) and LG-IR-NMIBC (Low-Grade, Intermediate-Risk, Non-Muscle Invasive Bladder Cancer). They are hoping to better understand the pros and cons of treatments like Zusduri, Valrubicin, or Epirubicin. After coming across your background on LinkedIn and seeing your experience in the industry, we thought you would be a great resource for my client. Ultimately, they would like to schedule a 60-minute compensated phone call with you to hear your perspective on this topic. Do you have 5 minutes sometime today for me to provide more details on this project and answer any questions you might have?
January 28, 2026 at 3:53 PM
ddayen.bsky.social
RFK Jr. is the nominee to run the agency that contains the FDA.
Soon-Shiong has a company with business before the FDA.
This isn't that hard.
ir.immunitybio.com/news-release...
January 31, 2025 at 10:03 PM
yawnyame.bsky.social
Day 2 highlights from #SUO24. We covered trial design for BCG unresponsive bladder cancer with @joshmeeks.bsky.social, upfront cystectomy in high-risk NMIBC with @vikramnarayan.bsky.social #vigneshpackiam & late breaking abstract on exciting intravesical chemo+immuno for high grade NMIBC
December 6, 2024 at 2:30 PM
brookmans76.bsky.social
#CREST trial with positive results for #PD-1 in HR #NMIBC!
✅The study evaluated #sasanlimab (PD-1i)+BCG vs standard #BCG (induction + maintenance) in BCG-naïve, HR NMIBC.
✅The study met its primary endpoint with significant improvement of EFS
pfizer.com/news/press-rel…
@oncodaily.bsky.social
https://pfizer.com/news/press-rel…
January 11, 2025 at 8:59 AM
oncoalert.bsky.social
Day 1 of #BLADDR24
Dr Kilian Gust
Debate: Are we ready to de-intensify treatment and surveillance in low-grade NMIBC?

CON
While de-intensification and surveillance in low-grade NMIBC may be appealing, it is premature

@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@achoud72.bsky.social
November 27, 2024 at 11:11 AM
oncodaily.bsky.social
New Research on CHAI Model for NMIBC Risk Stratification - Sabine D. Brookman-May

@brookmans76.bsky.social

oncodaily.com/voices/sabin...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Sabine D. Brookman-May: New Research on CHAI Model for NMIBC Risk Stratification - OncoDaily
Sabine D. Brookman-May: New Research on CHAI Model for NMIBC Risk Stratification / Anirudh Joshi, Badrinath R. Konety, Bryn Launer, cancer, Computational
oncodaily.com
October 25, 2025 at 7:58 PM
oncodaily.bsky.social
Updated Recommendations for Intermediate-Risk NMIBC - Ashish Kamat

@ashishkamatmd.bsky.social

oncodaily.com/voices/ashis...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #NMIBC #BladderCancer
Ashish Kamat: Updated Recommendations for Intermediate-Risk NMIBC - OncoDaily
Ashish Kamat: Updated Recommendations for Intermediate-Risk NMIBC / Ashish Kamat, Ashish M. Kamat, bladder cancer, Byron H. Lee, cancer, David J. McConkey,
oncodaily.com
October 12, 2025 at 10:26 PM
oncoalert.bsky.social
Day One of hashtag#BLADDR24
Presenter: Dr. Petros Grivas
High-risk BCG-unresponsive NMIBC: are we ready to delay/avoid RC?

@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
November 27, 2024 at 11:29 AM
wandering-gu.bsky.social
New SUO-CTC NMIBC research fellowship announced, funded by CG Oncology. Incredible credit to Ambaw Bellete 👏👏 and SUO-CTC leadership. #SUO24
December 5, 2024 at 10:22 PM
oncoalert.bsky.social
Day One of #BLADDR24
Dr. Ben-Max de Ruiter
High-risk BCG-naive NMIBC: should we stick to BCG?

@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
November 27, 2024 at 11:22 AM
dytcmd.bsky.social
#SUO24 #MarkTyson with great overview of expanding options in NMIBC #bladdercancer
Where we started…Where we are going #blcsm
Adjuvant bladder cancer treatments past to present Upcoming drug development for same space
December 5, 2024 at 6:07 PM
oncoalert.bsky.social
Day One of #BLADDR24
Dr Badrinath Konety
Can AI drive treatment decision-making in NMIBC?

Growing role of AI in non-muscle invasive bladder cancer care
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
November 27, 2024 at 8:44 AM
oncodaily.bsky.social
Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer: Agents, Strategies, Resistance, and Future Innovations

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Chemotherapy #IntravesicalChemotherapy #NMIBC #BladderCancer
Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer: Agents, Strategies, Resistance, and Future Innovations - OncoDaily
Intravesical chemotherapy is a key treatment for bladder cancer, reducing recurrence and progression in NMIBC with localized drug delivery and minimal toxicity.
oncodaily.com
July 15, 2025 at 11:08 PM
katesears.bsky.social
IBCG Risk Stratification Model for Intermediate-Risk NMIBC from @ashishkamatmd.bsky.social: myopenmedicine.com/algorithms/i...
IBCG Risk Stratification Model for Intermediate-Risk NMIBC
Intermediate-Risk Non–Muscle-Invasive Bladder Cancer (IR NMIBC) Risk Stratification Model by the International Bladder Cancer Group (IBCG).
myopenmedicine.com
June 2, 2026 at 2:34 PM
drnarayan.com
Enjoying a sparks flying crossfire in treatment BCG unresponsive NMIBC, special shout out to my partner @ssjoshi.bsky.social and my friends Vig Packiam, Cheryl Lee, William Huang, and @tullikagarg.bsky.social at #AUA2025
April 26, 2025 at 3:13 PM
oncoalert.bsky.social
Day One of #BLADDR24
Dr Cédric Lebâcle
Debate: Are we ready to de-intensify treatment and surveillance in low-grade NMIBC?
"pro" side: adapted de-intensification strategy offers several benefits.

@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
November 27, 2024 at 11:03 AM